Egypt vs Grenada: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Egypt
0.0%
in 2025
Grenada
0.0%
in 2025
Egypt rank
167th
Grenada rank
167th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Egypt
- Grenada
How they compare
Egypt currently reports 0.0% against 0.0% in Grenada, a difference of 0.0%.
Across all 18 years both countries report, Grenada has been ahead every year.
Egypt ranks 167th and Grenada ranks 167th of 194 countries.
Head to head by decade
| Decade | Egypt | Grenada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 0.0% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Egypt or Grenada?
- Egypt, at 0.0% against 0.0% in Grenada as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Egypt and Grenada?
- 0.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Grenada?
- 18 years are reported by both, from 2008 to 2025.
- How do Egypt and Grenada rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Egypt ranks 167th and Grenada ranks 167th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.